A Phase I/II Trial of Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy as Frontline Therapy for Older Patients with ALL

Publication date: September 2016 Source:Clinical Lymphoma Myeloma and Leukemia, Volume 16, Supplement 2 Author(s): Nicholas Short, Elias Jabbour, Susan O'Brien, Rita Khouri, Farhad Ravandi, Deborah Thomas, Guillermo Garcia-Manero, Koji Sasaki, Gautam Borthakur, Nitin Jain, Marina Konopleva, Jovitta Jacob, Rebecca Garris, Jorge Cortes, Hagop Kantarjian
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research